Adoptive T-cell immunotherapy of chronic lymphocytic leukaemia
- 30 September 2008
- journal article
- review article
- Published by Elsevier BV in Best Practice & Research Clinical Haematology
- Vol. 21 (3), 375-389
- https://doi.org/10.1016/j.beha.2008.08.002
Abstract
No abstract availableKeywords
This publication has 97 references indexed in Scilit:
- DDX3Y encodes a class I MHC–restricted H-Y antigen that is expressed in leukemic stem cellsBlood, 2008
- Clonogenic Multiple Myeloma Progenitors, Stem Cell Properties, and Drug ResistanceCancer Research, 2008
- CD38 expression labels an activated subset within chronic lymphocytic leukemia clones enriched in proliferating B cellsBlood, 2007
- Complete responses of relapsed lymphoma following genetic modification of tumor-antigen presenting cells and T-lymphocyte transferBlood, 2007
- Activation of the PTEN/mTOR/STAT3 pathway in breast cancer stem-like cells is required for viability and maintenanceProceedings of the National Academy of Sciences, 2007
- A Phase I Study on Adoptive Immunotherapy Using Gene-Modified T Cells for Ovarian CancerClinical Cancer Research, 2006
- Cancer Regression in Patients After Transfer of Genetically Engineered LymphocytesScience, 2006
- The polycomb group proteins, BMI-1 and EZH2, are tumour-associated antigensBritish Journal of Cancer, 2006
- Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cellNature Medicine, 1997
- Isolation and functional properties of murine hematopoietic stem cells that are replicating in vivo.The Journal of Experimental Medicine, 1996